News

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), a biopharmaceutical company specializing in inflammation and immunology (I&I) ...
Cellectar Biosciences, Inc. (NASDAQ:CLRB) stock is trading higher on Wednesday. As per data from Benzinga Pro, session volume ...
SHELTON, CT / ACCESS Newswire / June 4, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company ...
The city of Amsterdam will open a public consultation period where residents can weigh in on the capital’s contentious Erotic ...
Investing.com -- Shares of Tempest Therapeutics Inc (NASDAQ: TPST) climbed 5.3% following the announcement that the European Medicines Agency (EMA) has granted Orphan Drug Designation to its cancer ...
Iopofosine-131 received FDA breakthrough status for relapsed or refractory Waldenstrom macroglobulinemia, showing strong ...
There is "such positivity" in Alzheimer’s research at the moment, says top immunologist Luke O’Neill. A drug that slows down ...
Day One Biopharmaceuticals' Q1'25 sales grew modestly, but Q2 2025 earnings could spark movement. Read why I currently rate ...
Explore why food industry leaders are urging the EU to reform EFSA’s regulatory process. Learn how delays, high costs, and ...
Analysts reacted positively to the news that uniQure is in alignment with the FDA on an accelerated approval pathway and on ...
Basel: Roche has announced that the European Commission (EC) has approved a label extension for Evrysdi (risdiplam) to ...